A. Amin

921 total citations
27 papers, 713 citations indexed

About

A. Amin is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Amin has authored 27 papers receiving a total of 713 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Amin's work include Cancer Immunotherapy and Biomarkers (11 papers), CAR-T cell therapy research (8 papers) and Nutritional Studies and Diet (7 papers). A. Amin is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), CAR-T cell therapy research (8 papers) and Nutritional Studies and Diet (7 papers). A. Amin collaborates with scholars based in United States, Sudan and Australia. A. Amin's co-authors include M. Guillermo Herrera, Penelope Nestel, Wafaie Fawzi, Kamal A. Mohamed, Leisa Weld, Walter C. Willett, Martin H. Voss, Elizabeth R. Plimack, Hans J. Hammers and WC Willett and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and American Journal of Clinical Nutrition.

In The Last Decade

A. Amin

27 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Amin United States 15 272 195 170 161 112 27 713
Ettore Conti Italy 23 136 0.5× 681 3.5× 157 0.9× 185 1.1× 60 0.5× 41 1.6k
Stefanie A. Nelson United States 11 173 0.6× 71 0.4× 97 0.6× 149 0.9× 20 0.2× 22 525
Anna Christofides Canada 17 356 1.3× 188 1.0× 89 0.5× 83 0.5× 66 0.6× 41 927
Jacquelyn M. Powers United States 15 105 0.4× 48 0.2× 54 0.3× 106 0.7× 49 0.4× 47 782
M Fasoli Italy 20 116 0.4× 469 2.4× 31 0.2× 110 0.7× 53 0.5× 31 1.6k
Hans Christian Erichsen United States 10 98 0.4× 48 0.2× 66 0.4× 142 0.9× 160 1.4× 12 612
Salvatore Barra Italy 14 90 0.3× 437 2.2× 171 1.0× 229 1.4× 12 0.1× 23 1.4k
B Mathew India 16 82 0.3× 182 0.9× 71 0.4× 194 1.2× 21 0.2× 25 871
M. L. Slattery United States 9 114 0.4× 390 2.0× 135 0.8× 118 0.7× 5 0.0× 10 1.0k
Stefan de Vogel Netherlands 14 77 0.3× 110 0.6× 66 0.4× 211 1.3× 12 0.1× 23 676

Countries citing papers authored by A. Amin

Since Specialization
Citations

This map shows the geographic impact of A. Amin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Amin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Amin more than expected).

Fields of papers citing papers by A. Amin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Amin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Amin. The network helps show where A. Amin may publish in the future.

Co-authorship network of co-authors of A. Amin

This figure shows the co-authorship network connecting the top 25 collaborators of A. Amin. A scholar is included among the top collaborators of A. Amin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Amin. A. Amin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boilève, Alice, Maria I. Carlo, Philippe Barthélémy, et al.. (2018). Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders. Journal for ImmunoTherapy of Cancer. 6(1). 159–159. 59 indexed citations
2.
Long, Georgina V., Mohammed Milhem, A. Amin, et al.. (2018). Phase Ib/II, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are naïve to anti-PD-1 therapy. Annals of Oncology. 29. viii736–viii736. 4 indexed citations
3.
Ribas, A., Inderjit Mehmi, Theresa Medina, et al.. (2018). Phase Ib/II study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who had progressive disease on or after prior anti-PD-1 therapy. Annals of Oncology. 29. viii451–viii452. 6 indexed citations
4.
5.
Hammers, Hans J., Elizabeth R. Plimack, Jeffrey R. Infante, et al.. (2016). Updated results from a phase I study of nivolumab (Nivo) in combination with ipilimumab (Ipi) in metastatic renal cell carcinoma (mRCC): The CheckMate 016 study. Annals of Oncology. 27. vi364–vi364. 11 indexed citations
6.
Calvo, Emiliano, José A. López-Martín, Johanna C. Bendell, et al.. (2015). 3098 Nivolumab (NIVO) monotherapy or in combination with ipilimumab (IPI) for treatment of recurrent small cell lung cancer (SCLC). European Journal of Cancer. 51. S633–S633. 6 indexed citations
7.
Amin, A., Elizabeth R. Plimack, Jeffrey R. Infante, et al.. (2014). Nivolumab (N) (Anti-Pd-1; Bms-936558, Ono-4538) in Combination with Sunitinib (S) or Pazopanib (P) in Patients (Pts) with Metastatic Renal Cell Carcinoma (Mrcc). Annals of Oncology. 25. iv362–iv362. 20 indexed citations
8.
Hammers, Hans J., Elizabeth R. Plimack, Jeffrey R. Infante, et al.. (2014). Phase I Study of Nivolumab in Combination with Ipilimumab in Metastatic Renal Cell Carcinoma (Mrcc). Annals of Oncology. 25. iv361–iv361. 43 indexed citations
9.
Amin, A., Omid Hamid, Michele Maio, et al.. (2009). Evaluation of the effect of systemic corticosteroids for the treatment of immune-related adverse events (irAEs) on the development or maintenance of ipilimumab clinical activity. Journal of Clinical Oncology. 27(15_suppl). 9037–9037. 34 indexed citations
10.
Hwang, Jimmy J., A. Amin, Martin Rr, et al.. (2004). A phase I study of HYB2055 in patients (pts) with advanced solid malignancies. Journal of Clinical Oncology. 22(14_suppl). 3111–3111. 7 indexed citations
11.
Sedgh, Gilda, M. Guillermo Herrera, Penelope Nestel, A. Amin, & Wafaie Fawzi. (2000). Dietary Vitamin A Intake and Nondietary Factors Are Associated with Reversal of Stunting in Children. Journal of Nutrition. 130(10). 2520–2526. 32 indexed citations
12.
Fawzi, Wafaie, M. Guillermo Herrera, Walter C. Willett, et al.. (1997). The effect of vitamin A supplementation on the growth of preschool children in the Sudan.. American Journal of Public Health. 87(8). 1359–1362. 25 indexed citations
13.
Herrera, M. Guillermo, et al.. (1997). A prospective study of malnutrition in relation to child mortality in the Sudan. American Journal of Clinical Nutrition. 65(4). 1062–1069. 68 indexed citations
14.
Fawzi, Wafaie, M. Guillermo Herrera, Walter C. Willett, et al.. (1997). Dietary Vitamin A Intake in Relation to Child Growth. Epidemiology. 8(4). 402–402. 35 indexed citations
15.
Herrera, M. Guillermo, et al.. (1997). Risk factors of low dietary vitamin A intake among children in the Sudan.. PubMed. 74(4). 227–32. 9 indexed citations
16.
Fawzi, Wafaie, M. Guillermo Herrera, Walter C. Willett, et al.. (1995). Dietary Vitamin A Intake and the Incidence of Diarrhea and Respiratory Infection among Sudanese Children. Journal of Nutrition. 125(5). 1211–1221. 42 indexed citations
17.
Herrera, M. Guillermo, et al.. (1994). Dietary vitamin A intake and the risk of mortality among children. American Journal of Clinical Nutrition. 59(2). 401–408. 44 indexed citations
18.
Herrera, M. Guillermo, et al.. (1993). Vitamin A supplementation and dietary vitamin A in relation to the risk of xerophthalmia. American Journal of Clinical Nutrition. 58(3). 385–391. 25 indexed citations
19.
Nestel, Penelope, et al.. (1993). Risk Factors Associated with Xerophthalmia in Northern Sudan. Journal of Nutrition. 123(12). 2115–2121. 16 indexed citations
20.
Herrera, M. Guillermo, Penelope Nestel, Leisa Weld, et al.. (1992). Vitamin A supplementation and child survival. The Lancet. 340(8814). 267–271. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ettore Conti Breakdown of academic impact, for papers by Stefanie A. Nelson Breakdown of academic impact, for papers by Anna Christofides Breakdown of academic impact, for papers by Jacquelyn M. Powers Breakdown of academic impact, for papers by M Fasoli Breakdown of academic impact, for papers by Hans Christian Erichsen Breakdown of academic impact, for papers by Salvatore Barra Breakdown of academic impact, for papers by B Mathew Breakdown of academic impact, for papers by M. L. Slattery Breakdown of academic impact, for papers by Stefan de Vogel
Rankless by CCL
2026